IOL CHEMICALS & PHARM. | SUPRIYA LIFESCIENCE | IOL CHEMICALS & PHARM./ SUPRIYA LIFESCIENCE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 27.4 | 49.8% | View Chart |
P/BV | x | 1.6 | 4.7 | 32.9% | View Chart |
Dividend Yield | % | 1.0 | 0.1 | 685.1% |
IOL CHEMICALS & PHARM. SUPRIYA LIFESCIENCE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SUPRIYA LIFESCIENCE Mar-23 |
IOL CHEMICALS & PHARM./ SUPRIYA LIFESCIENCE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 515 | 104.1% | |
Low | Rs | 272 | 170 | 160.1% | |
Sales per share (Unadj.) | Rs | 377.6 | 50.4 | 749.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 11.2 | 212.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 12.6 | 249.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0.60 | 666.7% | |
Avg Dividend yield | % | 1.0 | 0.2 | 564.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 86.9 | 295.5% | |
Shares outstanding (eoy) | m | 58.71 | 80.48 | 72.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 6.8 | 15.7% | |
Avg P/E ratio | x | 17.1 | 30.7 | 55.6% | |
P/CF ratio (eoy) | x | 12.8 | 27.1 | 47.2% | |
Price / Book Value ratio | x | 1.6 | 3.9 | 39.9% | |
Dividend payout | % | 16.9 | 5.4 | 314.0% | |
Avg Mkt Cap | Rs m | 23,743 | 27,581 | 86.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 556 | 302.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 4,054 | 546.9% | |
Other income | Rs m | 256 | 100 | 256.3% | |
Total revenues | Rs m | 22,427 | 4,154 | 539.9% | |
Gross profit | Rs m | 2,257 | 1,284 | 175.7% | |
Depreciation | Rs m | 462 | 118 | 390.7% | |
Interest | Rs m | 165 | 31 | 525.9% | |
Profit before tax | Rs m | 1,887 | 1,235 | 152.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 336 | 147.2% | |
Profit after tax | Rs m | 1,391 | 899 | 154.8% | |
Gross profit margin | % | 10.2 | 31.7 | 32.1% | |
Effective tax rate | % | 26.2 | 27.2 | 96.4% | |
Net profit margin | % | 6.3 | 22.2 | 28.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 4,649 | 207.9% | |
Current liabilities | Rs m | 5,025 | 958 | 524.7% | |
Net working cap to sales | % | 20.9 | 91.0 | 23.0% | |
Current ratio | x | 1.9 | 4.9 | 39.6% | |
Inventory Days | Days | 43 | 24 | 183.3% | |
Debtors Days | Days | 8 | 76 | 10.9% | |
Net fixed assets | Rs m | 11,017 | 3,554 | 310.0% | |
Share capital | Rs m | 587 | 161 | 364.7% | |
"Free" reserves | Rs m | 14,490 | 6,834 | 212.0% | |
Net worth | Rs m | 15,077 | 6,995 | 215.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 8,203 | 252.2% | |
Interest coverage | x | 12.5 | 40.4 | 30.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.5 | 216.9% | |
Return on assets | % | 7.5 | 11.3 | 66.4% | |
Return on equity | % | 9.2 | 12.8 | 71.8% | |
Return on capital | % | 13.6 | 18.1 | 75.2% | |
Exports to sales | % | 26.7 | 88.8 | 30.1% | |
Imports to sales | % | 0 | 23.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 3,598 | 164.8% | |
Imports (cif) | Rs m | NA | 953 | 0.0% | |
Fx inflow | Rs m | 5,930 | 3,598 | 164.8% | |
Fx outflow | Rs m | 6,052 | 953 | 634.9% | |
Net fx | Rs m | -122 | 2,645 | -4.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 662 | 184.7% | |
From Investments | Rs m | -1,200 | -1,331 | 90.1% | |
From Financial Activity | Rs m | -41 | -34 | 122.1% | |
Net Cashflow | Rs m | -18 | -703 | 2.6% |
Indian Promoters | % | 48.2 | 68.3 | 70.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 10.7 | 15.9% | |
FIIs | % | 1.4 | 5.4 | 26.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 31.7 | 163.4% | |
Shareholders | 130,003 | 87,980 | 147.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SUPRIYA LIFESCIENCE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | -0.67% | 0.45% |
1-Month | 5.76% | 23.23% | 2.55% |
1-Year | -2.63% | 89.89% | 56.14% |
3-Year CAGR | -12.88% | 1.70% | 15.22% |
5-Year CAGR | 16.82% | 1.01% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SUPRIYA LIFESCIENCE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SUPRIYA LIFESCIENCE the stake stands at 68.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SUPRIYA LIFESCIENCE .
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SUPRIYA LIFESCIENCE paid Rs 0.6, and its dividend payout ratio stood at 5.4%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SUPRIYA LIFESCIENCE .
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.